Flemming Ørnskov Explained

Flemming Ørnskov
Nationality:Danish
Alma Mater:University of Copenhagen
INSEAD
Harvard University
Occupation:CEO, Galderma

Flemming Ørnskov (born 1957/58) is a Danish businessman. He has been the chief executive officer (CEO) of Galderma since October 2019.

He was previously the CEO of Shire plc, a FTSE 100 specialty biopharmaceutical company as of 30 April 2013, succeeding Angus Russel.[1] He previously worked for Bayer, Bausch & Lomb and Novartis.[2]

He is also the non-executive chairman of Waters Corporation, a position he's been holding since 2017.[3] [4]

Ørnskov received his MD from the University of Copenhagen, followed by an MBA from INSEAD, and a Master of Public Health (MPH) from Harvard University.[5]

Ørnskov led Galderma's IPO on the Zurich stock exchange on March 22, 2024, one of the biggest offerings in Europe in years and the biggest in Switzerland since 2017.[6] [7] He declares Galderma plans to use the proceeds to pay down debt and invest in its pipeline.[8]

Awards

Top 100 Best-Performing CEOs in the World, 2015 - Harvard Business Review[9]

Top 25 Most Influential People in Biopharma Today, 2013 - Fierce Biotech[10]

Notes and References

  1. Web site: Shire chief finds right prescription for growth. The Telegraph. 29 December 2013 . 20 March 2014.
  2. News: Liu . Angus . Ex-Shire CEO Flemming Ornskov emerges as Galderma CEO after $10B Nestlé spinout . Fiercepharma . October 8, 2019 . Prior to Shire, Ornskov had plenty of experience from his work at Bayer, Bausch & Lomb and Novartis. Dittrich was only Shire’s CFO for a year, but he’s not so new to pharma, either, having previously served a stint at Amgen..
  3. Web site: Conseil d'administration : Waters. 2021-04-01. www.waters.com.
  4. Web site: June 2, 2017 . Waters Corporation Elects Flemming Ornskov to Board of Directors . June 21, 2024 . Business Wire.
  5. Web site: Executive Profile: Flemming Ornskov . Bloomberg. 4 September 2017.
  6. Web site: Swetha Gopinath and Allegra Catelli . 2024-03-22 . Galderma Surges in Debut, Bolstering Europe IPO Recovery . 2024-06-14 . www.bloomberg.com.
  7. Web site: 2024-03-22 . GALDERMA STOCK SURGES IN DEBUT ON SWISS STOCK EXCHANGE SIX . 2024-06-14 . Beauty Matter.
  8. Web site: 2024-03-07 . EQT’s Galderma Seeks to Raise $2.3 Billion in Swiss Listing . 2024-06-14 . The Business of Fashion . en.
  9. Web site: The 'best-performing' CEO in the world is a pharma chief. 2021-04-01. BioPharma Dive. en-US.
  10. Web site: The 25 most influential people in biopharma today - 2013. 2021-04-01. FierceBiotech. en.